September 21, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Yokogawa Technology Selected for JSTA's Next-generation Technology Transfer Program
 

Tokyo, Aug 8, 2014 (JCN) - Yokogawa Electric announced that its confocal image single-cell drug discovery support system has been selected for the Japan Science and Technology Agency's (JST) next-generation technology transfer program (NexTEP). NexTEP was created to promote efforts by companies to find practical applications for the technologies (including those covered by patents) and research findings of universities and public research institutions.

Through this undertaking, JST aims to develop a new drug-discovery support system that will integrate a single-cell mass spectrometry method developed by the RIKEN Quantitative Biology Center's Laboratory for Single Cell Mass Spectrometry with high-speed imaging and high-precision positioning technologies that Yokogawa has developed for its confocal scanner units and drug-discovery support devices.

For the development of new drugs, multiple cells are typically ground to analyze intracellular metabolism and thereby verify the efficacy and side effects of a particular candidate drug. A drawback of this technique is that molecular changes in individual cells cannot be analyzed in sufficient detail. In addition, large numbers of animal and human cells are required.

With this new system, JST aims to clarify how molecules of a candidate drug reach a specific cell and the changes that take place there. Single-cell mass spectrometry is a technique for the analysis of target molecules that have been suctioned out from individual cells as they are being observed under a microscope.

The system that is to be developed will speed up this process by automating the identification of cells and molecules where unusual changes have taken place, and automatically capturing target molecules. In addition to speeding up analysis, this will reduce costs.

Yokogawa will work with RIKEN to develop a system that will accelerate the development of new drugs by enabling the quick and precise analysis of the effect that candidate drugs have on intracellular metabolism.


By Jun Ota Staff Writer

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Yokogawa Electric News  
  Yokogawa Technology Selected for JSTA's Next-generation Technology Transfer Program  (Aug 8, 2014)
  Yokogawa Wins Order for Saudi Arabia's First Supercritical Thermal Power Plant  (May 14, 2014)
  Yokogawa Wins Orders for Chinese Coal/Oil Co-processing Pilot Plant and Coal Tar Hydrogenation Plant Projects  (Mar 26, 2014)
  Yokogawa Wins Major Contract for One of the UK's Largest Onshore Gas Storage Facilities  (July 17, 2013)
  Yokogawa Wins Control System Order for Municipal Water Treatment Plant in Indonesia  (July 12, 2013)
  Yokogawa and Soteica Visual MESA Tie-up for Energy Management Solutions Business  (Feb 11, 2013)
  Yokogawa Awarded Control System Order for Korean Large Combined Cycle Power Plant  (Jan 21, 2013)
  IHI, Xenesys and Yokogawa Win Experimental Deep Seawater Power Generation Project  (July 20, 2012)
  Yokogawa Receives FEED Contract from CJV for Arrow LNG Project  (Dec 16, 2011)
  Yokogawa Inks Network Switch Supply Agreement with Belden  (Oct 25, 2011)



 Recent  Medical News   
Mitsui to Participate in KIFMEC Specific Purpose Company (Aug 18, 2014)
Yokogawa Technology Selected for JSTA's Next-generation Technology Transfer Program (Aug 8, 2014)
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)
EIZO, Stryker to Partner in Monitor Management Systems for Operating Rooms (Oct 8, 2013)
HOYA to Invest in EndoMaster, for Robotic-assisted Surgical Systems (Aug 19, 2013)

More Medical news...
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)